Scoliosis Management Market

Scoliosis Management Market to Exhibit Profitable Growth During the Forecast Period

The global scoliosis management market is rapidly expanding; it was worth US$ 1,792.4 million in 2017 and is expected to be worth US$ XX million by 2026. Increasing surgical procedures, treatment with support braces and exercises, and minimally invasive therapies, as well as the increasing prevalence of scoliosis diseases, will drive overall market growth during the forecast period. In addition, new technological signs of progress in scoliosis braces and favorable private and public initiatives in the medical sector across various developing countries will further assist in the overall growth of the scoliosis management market. The increasing prevalence of adolescent idiopathic scoliosis (AIS) in the U.S. and globally is a major concern. The total cost of treating AIS was estimated to be around $514 million in 2009. The essential nonsurgical treatment for AIS is bracing, whose objective is to minimize the requirement for surgical or other major medical procedures by constraining curve movement. Numerous scoliosis curve lines less than 20° in AIS can be screened and followed with serial radiographs or other clinical examinations every six months until skeletal development.

As indicated by the National Scoliosis Foundation (NSF), around 2 to 3% of the overall population experiences scoliosis in the U.S. Around six to nine million individuals suffer from this disorder. More than 600,000 patients visit private clinics and hospitals every year; around 30,000 young people are utilizing braces, and nearly 38,000 patients have experienced spinal surgery and other medical procedures. All these components are responsible for driving the overall growth of the scoliosis management industry during the forecast period. Technological developments in scoliosis management, both in invasive and noninvasive treatment procedures, are boosting the demand, primarily in the Asia Pacific and Europe.

Market Synopsis

The Thoracolumbosacral Orthosis (TLSO) Brace Segment is expected to register higher growth by the end of 2026.

In the past decade, various studies and research have shown that the regular history of adolescent idiopathic scoliosis (AIS) can be emphatically influenced by nonoperative treatment, particularly bracing. Different types of treatment, for example, osteopathic or chiropractic therapy, needle therapy (acupuncture), exercise or other manual medications, or diet and nourishment, have not yet been proven to be compelling in controlling spinal deformities in scoliosis management. Nonoperative treatment with a thoracolumbosacral orthosis (TLSO) is widely utilized. Scoliosis is mainly observed in around 3% of the younger population, less than 16 years old. Adolescent idiopathic scoliosis (AIS) is usually observed in individuals aged 11 years and older. Thoracolumbosacral orthosis braces are gaining traction across the globe and are primarily utilized in the end-user segment. Bracing treatment with a thoracolumbosacral orthosis (TLSO) is mainly indicated for skeletally juvenile patients with AIS with a normal bend of 25° to 45°.

Numerous types of TLSOs have been manufactured around the world, for example, Boston, Providence, Wilmington, and Rosenberg braces in North America; TLSO Hiroshima in Japan; Chêneau and Sforzesco braces in Europe; the OMC (Osaka Medical College) brace; the Chiba brace high type; and others. The custom-made TLSOs are also in demand for the right reflex arrangement, mainly for the active correction of the upper thoracic curve. The fundamentals of custom-made braces are characterized by their unremarkable design, lightweight, lessening of restriction on chest wall movement, and capability to precisely correct the high thoracic curve by restoring the reflex in the body. However, a few complications occur during the overall treatment cycle, such as physiological disturbance, skin color change, irritation, and other problems related to the respiratory system.

The Hospitals & Clinics Segment is expected to grow faster by the end of 2026.

As indicated by an article in the journal Back and Musculoskeletal Rehabilitation in 2014, scoliosis is observed in around 3% of individuals all around the globe, most usually among young females. In addition, expanded use of healthcare service benefits by patients in hospitals with scoliosis conditions, adoption of new 3D printing technology products, braces with tracking devices, and major utilization of customized braces are driving the development of the worldwide scoliosis management market. For example, as indicated by the United States Bone and Joint Initiative report, in 2011, around 229,000 individuals were hospitalized with scoliosis conditions. Higher treatment, surgery, and therapy costs, as well as less favorable outcomes in various scoliosis cases, are impeding the growth of the scoliosis management market. According to a research study published in the Spine Journal in 2010, the normal mean expenses of nonsurgical care for scoliosis management were estimated to be as high as US$ 14,000 over a two-year period. The average cost to the patient for scoliosis surgery is around $110,000.

The rising prevalence of scoliosis, combined with minimally invasive procedures and the presence of established players, keeps North America in the lead.

North America spearheaded the market in 2017 owing to the presence of established players and the increasing prevalence of scoliosis in children, mainly adolescent idiopathic scoliosis (10–18 years of age). Also, growing concerns about patient welfare among clinicians, an increasing population, and the development of novel scoliosis braces are driving the growth of the industry during the forecast period in North America. Asia Pacific is expected to register a comparatively higher CAGR over the forecast period due to the rising number of patient admissions and growing awareness among the end users about newly manufactured custom-based scoliosis braces in the thoracolumbosacral orthosis (TLSO) and CTLSO (Cervical Thoracic Lumbar Sacral Orthosis). Additionally, a high incidence of scoliosis disorder, an increase in the adoption rate of branded braces in developing nations, technology assessment with new tracking devices, and rising demand for noninvasive therapies and medications, along with awareness, are expected to drive the market for scoliosis management during the forecast period.

Market penetration for emerging players is difficult due to the dominance of established multinational players with strong product portfolios.

Major players in the scoliosis management market are Aspen Medical Products Inc., DJO Global, Ottobock, Horton’s Orthotics & Prosthetics, Boston O&P, TRU LIFE, Bauerfeind AG, Spinal Technology Inc., Fitted, Wellinks, Inc., and others. These manufacturers are implementing growth strategies along with new technology assessments in braces, partnerships with hospitals and medical technology companies, mergers and acquisitions, and alliances to increase economic benefits. For instance, in May 2017, the UNYQ Align scoliosis brace was selected for permanent demonstration at the Cooper Hewitt Smithsonian Design Museum in the U.S. This particular brace has advanced 3D printing capabilities and is fabricated with topographic anatomical analysis.

Periods of History and Forecast

This study report includes an analysis for each segment from 2016 to 2026, with 2017 as the base year. The compound annual growth rate (CAGR) for each of the respective segments is estimated for the forecast period from 2018 to 2026.

Report Scope by Segments

The scoliosis management market comprises current market trends and dynamics along with a quantitative analysis of the global market. The report elucidates thorough information about the global scoliosis management market by segmenting the market in terms of product, modality, end-user, and geography. This report will assist healthcare professionals and market participants in making decisions and strategizing market positions.

The current report also encompasses qualitative market assessment factors such as market trends, key market drivers, restraints, and opportunities that give a better understanding of the overall scoliosis management market. Furthermore, the report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolios, and business strengths. Key industrial players profiled in the study report are Aspen Medical Products Inc., DJO Global, Ottobock, Horton’s Orthotics & Prosthetics, Boston O&P, TRU LIFE, Bauerfeind AG, Spinal Technology Inc., Fitted, Wellinks, Inc., and others.

Key questions are answered in this report.

• What are the current market trends and dynamics in the scoliosis management market, and what are the valuable opportunities for emerging players?
• What is the market positioning of the major market players?
• Which segment accounts for the fastest CAGR during the forecast period?
• Which end-user holds a larger market share and why?
• What is the impact of the high cost of braces and surgery on the scoliosis management market?
• Are low- and middle-income economies investing in the scoliosis management market?
• What are the market trends and dynamics in emerging markets such as Japan, Latin America, the Middle East, and Africa?

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global SM Market Portraiture
2.2. Global SM Market, By Product Type, 2017 (US$ Mn)
2.3. Global SM Market, By End User, 2017 (US$ Mn)
2.4. Global SM Market, by Geography, 2017 Vs 2026 (Value %)

Chapter 3. Global Scoliosis Management (SM) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Scoliosis Management Technologies: Future Trends
3.3. Current Scenario: Strategies Used for Drug Delivery Across BBB Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2017
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Scoliosis Management (SM) Market, by Product Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. CTLSO (Cervical Thoracic Lumbar Sacral Orthosis) Brace
4.3. TLSO (Thoracolumbosacral Orthosis) Brace
4.4. Lumbosacral Orthosis (LSO) Brace

Chapter 5. Global Scoliosis Management (SM) Market, By End User, 2016 – 2026 (US$)
5.1. Overview
5.2. Hospitals & Clinics
5.3. Retail Pharmacies
5.4. Online Pharmacies

Chapter 6. Global Scoliosis Management (SM) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America SM Market Analysis, 2016 – 2026
6.2.1. North America SM Market, By Product Type, 2016 – 2026 (US$ Mn)
6.2.2. North America SM Market, By End User, 2016 – 2026 (US$ Mn)
6.2.3. North America SM Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe SM Market Analysis, 2016 – 2026
6.3.1. Europe SM Market, By Product Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe SM Market, By End User, 2016 – 2026 (US$ Mn)
6.3.3. Europe SM Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific SM Market Analysis, 2016 – 2026
6.4.1. Asia Pacific SM Market, By Product Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific SM Market, By End User, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific SM Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America SM Market Analysis, 2016 – 2026
6.5.1. Latin America SM Market, By Product Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America SM Market, By End User, 2016 – 2026 (US$ Mn)
6.5.3. Latin America SM Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) SM Market Analysis, 2016 – 2026
6.6.1. MEA SM Market, by Product Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA SM Market, By End User, 2016 – 2026 (US$ Mn)
6.6.3. MEA SM Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Aspen Medical Products Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. DJO Global
7.3. Ottobock
7.4. Horton’s Orthotics & Prosthetics
7.5. Boston Orthotics & Prosthetics
7.6. TRULIFE.
7.7. Bauerfeind AG
7.8. Spinal End User Inc.
7.9. Fited
7.10. Wellinks, Inc.

List of Figures

FIG. 1 Global Scoliosis Management (SM) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global SM Market Segmentation
FIG. 4 Global SM Market, by Product Type, 2017 (US$ Mn)
FIG. 5 Global SM Market, by End User, 2017 (US$ Mn)
FIG. 6 Global SM Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Geography, 2017
FIG. 8 Global Market Positioning of Key Scoliosis Management Manufacturers, 2017
FIG. 9 Global Cervical Thoracic Lumbar Sacral Orthosis (CTLSO) Brace Market, 2016–2026 (US$ Mn)
FIG. 10 Global Thoracolumbosacral Orthosis (TLSO) Brace Market, 2016–2026 (US$ Mn)
FIG. 11 Global Lumbosacral Orthosis (LSO) Brace Market, 2016–2026 (US$ Mn)
FIG. 12 Global Hospitals & Clinics Market for Scoliosis Management, 2016–2026 (US$ Mn)
FIG. 13 Global Retail Pharmacies Market for Scoliosis Management, 2016–2026 (US$ Mn)
FIG. 14 Global Online Pharmacies Market for Scoliosis Management, 2016–2026 (US$ Mn)
FIG. 15 U.S. SM Market, 2016–2026 (US$ Mn)
FIG. 16 Canada SM Market, 2016–2026 (US$ Mn)
FIG. 17 U.K. SM Market, 2016–2026 (US$ Mn)
FIG. 18 Germany SM Market, 2016–2026 (US$ Mn)
FIG. 19 Rest of Europe SM Market, 2016–2026 (US$ Mn)
FIG. 20 Japan SM Market, 2016–2026 (US$ Mn)
FIG. 21 China SM Market, 2016–2026 (US$ Mn)
FIG. 22 Rest of Asia Pacific SM Market, 2016–2026 (US$ Mn)
FIG. 23 Brazil SM Market, 2016–2026 (US$ Mn)
FIG. 24 Mexico SM Market, 2016–2026 (US$ Mn)
FIG. 25 Rest of Latin America SM Market, 2016–2026 (US$ Mn)
FIG. 26 GCC SM Market, 2016–2026 (US$ Mn)
FIG. 27 Rest of Middle East & Africa SM Market, 2016–2026 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Scoliosis Management (SM) Market
TABLE 2 Global SM Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 3 Global SM Market, by End User, 2016–2026 (US$ Mn)
TABLE 4 Global SM Market, by Geography, 2016–2026 (US$ Mn)
TABLE 5 North America SM Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 6 North America SM Market, by End User, 2016–2026 (US$ Mn)
TABLE 7 North America SM Market, by Country, 2016–2026 (US$ Mn)
TABLE 8 Europe SM Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 9 Europe SM Market, by End User, 2016–2026 (US$ Mn)
TABLE 10 Europe SM Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 11 Latin America SM Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 12 Latin America SM Market, by End User, 2016–2026 (US$ Mn)
TABLE 13 Latin America SM Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 14 Asia Pacific SM Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 15 Asia Pacific SM Market, by End User, 2016–2026 (US$ Mn)
TABLE 16 Asia Pacific SM Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 17 Latin America SM Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 18 Latin America SM Market, by End User, 2016–2026 (US$ Mn)
TABLE 19 Latin America SM Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 20 Middle East & Africa SM Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 21 Middle East & Africa SM Market, by End User, 2016–2026 (US$ Mn)
TABLE 22 Middle East & Africa SM Market, by Region, 2016–2026 (US$ Mn)
TABLE 23 Aspen Medical Products Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 DJO Global: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 Ottobock: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 Horton’s Orthotics & Prosthetics: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Boston Orthotics & Prosthetics.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 TRULIFE.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 Bauerfeind AG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Spinal End User Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 Fited: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 Wellinks, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)